X-101275266-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001168474.2(TAF7L):​c.1042G>C​(p.Val348Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,164,382 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000028 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000012 ( 0 hom. 3 hem. )

Consequence

TAF7L
NM_001168474.2 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.878
Variant links:
Genes affected
TAF7L (HGNC:11548): (TATA-box binding protein associated factor 7 like) This gene is similar to a mouse gene that encodes a TATA box binding protein-associated factor, and shows testis-specific expression. The encoded protein could be a spermatogenesis-specific component of the DNA-binding general transcription factor complex TFIID. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.20049512).
BS2
High Hemizygotes in GnomAdExome4 at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF7LNM_001168474.2 linkc.1042G>C p.Val348Leu missense_variant Exon 12 of 13 ENST00000356784.2 NP_001161946.1 Q5H9L4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF7LENST00000356784.2 linkc.1042G>C p.Val348Leu missense_variant Exon 12 of 13 1 NM_001168474.2 ENSP00000349235.1 Q5H9L4-2
TAF7LENST00000372907.7 linkc.1300G>C p.Val434Leu missense_variant Exon 12 of 13 1 ENSP00000361998.3 Q5H9L4-1
TAF7LENST00000324762.10 linkc.820G>C p.Val274Leu missense_variant Exon 10 of 11 2 ENSP00000320283.6 Q5H9L4-3

Frequencies

GnomAD3 genomes
AF:
0.0000278
AC:
3
AN:
107850
Hom.:
0
Cov.:
23
AF XY:
0.0000323
AC XY:
1
AN XY:
30986
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000999
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00139
GnomAD3 exomes
AF:
0.0000191
AC:
3
AN:
157212
Hom.:
0
AF XY:
0.0000201
AC XY:
1
AN XY:
49682
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000914
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000136
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000123
AC:
13
AN:
1056532
Hom.:
0
Cov.:
25
AF XY:
0.00000907
AC XY:
3
AN XY:
330642
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000970
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000122
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000278
AC:
3
AN:
107850
Hom.:
0
Cov.:
23
AF XY:
0.0000323
AC XY:
1
AN XY:
30986
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000999
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00139
Bravo
AF:
0.0000642
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 14, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1300G>C (p.V434L) alteration is located in exon 12 (coding exon 12) of the TAF7L gene. This alteration results from a G to C substitution at nucleotide position 1300, causing the valine (V) at amino acid position 434 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.2
DANN
Benign
0.96
DEOGEN2
Benign
0.061
T;.;.
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.66
T;T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.20
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;.;.
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.7
N;N;N
REVEL
Benign
0.050
Sift
Benign
0.14
T;T;T
Sift4G
Benign
0.26
T;T;T
Polyphen
0.38
B;B;.
Vest4
0.16
MutPred
0.15
Loss of MoRF binding (P = 0.2208);.;.;
MVP
0.14
MPC
0.43
ClinPred
0.11
T
GERP RS
4.3
Varity_R
0.077
gMVP
0.055

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs779428440; hg19: chrX-100530254; API